Prev：Repurposing of epalrestat for neuroprotection in parkinson’s disease via activation of the KEAP1/Nrf2 pathway.(KTP3001-10.1)
Next：Research on the interaction of protein Tmub1 and securin after partial hepatectomy(ABL1030-15)
